www.fdanews.com/articles/70659-protein-polymer-reports-new-equity-investment
Protein Polymer Reports New Equity Investment
April 4, 2005
Protein Polymer Technologies reported that a small group of institutional and accredited investors committed $4,200,330 for the purchase of an aggregate of 12,728,269 shares of the company's common stock together with warrants for the purchase of an aggregate of approximately 6,364,132 shares of common stock. The common stock was priced at $0.33 per share. Of the committed capital, approximately $1.2 million represents the conversion of short term promissory notes previously issued by the company.